Best practice guidelines and multidisciplinary pathways of care are becoming an established and essential feature of clinical practice. They can be seen in a wide variety of clinical settings ranging right across the primary, secondary and tertiary health and social care spectrums. The 1997 White Paper places strong emphasis on quality and consistency of care delivery and gives assurances of performance measurements, integrated care (Wilson, 1996) and clinical governance. It suggests making healthcare delivery against national standards a local responsibility and quality of care the driving force for decision making at every level of the service to ensure excellence for patients no matter where the care is provided. A number of controversial issues surround the use of guidelines. Some argue that they are a fetter on clinical discretion, clinical freedom and can lead to the practice of 'cookbook medicine'. Others maintain that they are an essential aid to providing safe and appropriate medical and nursing care.
[1]
C. Vincent,et al.
Adverse events in British hospitals: preliminary retrospective record review
,
2001,
BMJ : British Medical Journal.
[2]
ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy.
,
1995,
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[3]
E. Ackermann.
The Quality in Australian Health Care Study.
,
1996,
The Medical journal of Australia.
[4]
Jonathan M. Teich,et al.
Identifying hospital admissions due to adverse drug events using a computer‐based monitor
,
2001,
AMIA.
[5]
Rainu Kaushal,et al.
Computerized Physician Order Entry ( CPOE ) with Clinical Decision Support Systems ( CDSSs )
,
2001
.